SCHEMBL7511633

SCHEMBL7511633

CC(C)(C)OC(=O)N1CCC(O)(Cc2ccc3ccccc3n2)CC1

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.45
CYP11B2 P19099 1/20 0.44
NOTCH1 P46531 1/20 0.44
PDE10A Q9Y233 4/20 0.43
GPR4 P46093 1/20 0.42
OPRD1 P41143 1/20 0.42
OPRK1 P41145 1/20 0.42
CCR5 P51681 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
FAAH O00519 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16049607 0.82 GPR4 (0.49) CYP11B2GPR4OPRD1OPRK1ALOX15
SCHEMBL29686152 0.82 GPR4 (0.49) CYP11B2GPR4OPRD1OPRK1ALOX15
SCHEMBL1054762 0.81 POLB (0.43) CYP11B2GPR4OPRD1OPRK1MEN1
SCHEMBL16049825 0.81 PKLR (0.48) CYP11B2GPR4OPRD1OPRK1ALOX15
SCHEMBL30585014 0.81 CYP46A1 (0.54) OPRD1OPRK1TSHR
SCHEMBL6619420 0.81 BACE1 (0.49) BACE1CYP11B2NOTCH1PDE10AOPRD1
SCHEMBL1088021 0.81 CYP46A1 (0.54) OPRD1OPRK1TSHR
SCHEMBL26081092 0.79 IDH1 (0.49) CYP11B2PDE10AGPR4OPRD1OPRK1
SCHEMBL2951728 0.78 OPRD1 (0.53) OPRD1OPRK1ALOX15TSHRATM
SCHEMBL513434 0.78 CCR5 (0.42) CYP11B2OPRD1OPRK1CCR5KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0905134-B1 Piperidine derivatives as LTD4 and H1 antagonists KOWA CO (JP) 2002-01-16 EP disclosed
US-6107308-A ANTIHISTAMINE; LEUTRIENE ANTAGONIST KOWA CO., LTD. (JP) 2000-08-22 US disclosed
EP-0905134-A1 Piperidine derivatives as LTD4 and H1 antagonists KOWA COMPANY, LTD. (JP) 1999-03-31 EP disclosed